Macleods

3,218 views

Published on

Published in: Education, Business, Career
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total views
3,218
On SlideShare
0
From Embeds
0
Number of Embeds
8
Actions
Shares
0
Downloads
70
Comments
0
Likes
1
Embeds 0
No embeds

No notes for slide

Macleods

  1. 1. Group no-01Animesh Amal (01)Bhavika Sachdev(23)Ruhita Indulkar (09)Tushar Bhoshle (07)
  2. 2. Contents• Outline• Introduction and Background• Vision and Mission• Manufacturing• Indian Business• International Business• R & D• Divisions• New developed and launched Drugs• Organization Chart• Career Opportunity• References
  3. 3. Introduction and Background• Incorporated in 1986 by Dr. Rajendra Agarwal• Global Healthcare Company with Experience Spanning twodecades• Multiple Location Organization, Mumbai being the IndianHeadquarter• Has its presence in more than 80 countries like South EastAsia, Asia Pacific ,Africa, North America, EU, Latin America etc• Expertise in range of formulations ranging from tablets tosterile dosage form and from inhalation to novel drug deliverysystem.• Currently Ranked 11th in the Indian Pharmaceutical Company
  4. 4. Vision and MissionVision• To become a leading global pharmaceutical company by providinghigh quality, affordable and innovative therapeutic solutions forpatients with diverse medical needs.Mission• To provide affordable drugs for essential therapies like TB, malaria& HIV• To continue to have the 1st mover advantage in the domesticmarket in various therapeutic segments• To be a strong vertically integrated global generic manufacturer.
  5. 5. Product PortfolioMacleod’s product portfolio encompasses a wide spectrum oftherapeutic groups, ranging from :• Anti-TB• Asthma & COPD• Anti bacterial• NSAIDS• Anti-arthritic• Anti-osteoporotic,• Gastroenterology,• Gynaecology• Diabetology and• CVS products.
  6. 6. SWOT• Strength• Strong R&D• Global Leader• Strong ManufacturingUnit• Weakness• New company• No disclosure ofinformation on theinternet
  7. 7. Opportunities and Threats• Growing incomes andlifestyle diseases• Spreading use ofgeneric drugs• Spreading attitude forOTC drugs• Strong competition• Competition for genericproducts
  8. 8. ManufacturingLocation AddressBaddiVillage: Theda, Kharuni- Lodimajra,Thehesil- Nalagarh,Baddi Industrial Estate Area,Dist: Solan. Himachal PradeshPalgharPlotNo.1, Mahim Road,Near Kuldeep Hotel,Palghar (W), 401404Dist: ThaneDaman- Premier- Unit IIPlot no. 25-27Survey No. 366,Premier Industrial Estate,KachigamDaman- 396320Daman- Kabra- Unit IIIPlot No. 367/ 7Kabra Industrial Estate,Kachigam,Daman- 396210SarigamPlot No.2209GIDC Sarigam,Dist: ValsadAPIs
  9. 9. International Business• Macleods has its presence in more than 80countries.SouthEastAsiaAsiaPacificAfricaNorthAmericaEU & EEAMENALatinAmericaCIScountries US
  10. 10. Continued…• Macleods operates its International business through variousbusiness models like• Private Markets• Tenders• Licensing• Contract manufacturing• Joint Ventures
  11. 11. • Macleods has established its Representativeoffice in the• CIS countries• Africa• South East Asia and• Latin Americalooking into the business potential and thenecessity of being at the centre of action.
  12. 12. Research & Development• Macleods R & D centre is located in Mumbai,which was setup in the year 2000.R&D centre of Macleods is having following basicinterests Chemical Research & DevelopmentDepartment Formulation Development Department Analytical Research & DevelopmentDepartment Bioequivalence study Centre
  13. 13. MACLEODS DIVISONSName of Division ProductsMacphar Acufix , Algesi, GramanaxaAcuphar Acuclav , Kefpime, OflomacGencare Acudrox , Domizol, Bio d3Pharma Azunate , Geminex , OndamacProcare AHT Alista , Mefomin , GabaminTB care Forecox , Moximac ,ZedocefProcare CV Amlovas , Atormac , Zetivas
  14. 14. Macleods has been the first in the world tohave developed and launched:FORECOX : A four-drug fixed dose combination of RHZE for TB.RABEMAC-DSR : Combination of Rabeprazole plus Domperidone SRtablets)ZITHROX : Azithromycin in Intestinal Transport Modulation (ITM)TechnologyTRENAXA MF : Combination of Tranexamic Acid and Mefenamic acidfor the treatment of Menorrhagia.OMNACORTIL : Prednisolone with BCDCEFOLAC : Cefixime plus Lactic acid bacillus , and many moreformulations which have attained leadership in their respectivetherapeutic categories.
  15. 15. Organization ChartManaging DirectorMarketing Director Finance DirectorHR Manager Plant Manager R & D ManagerAccounts ManagerMarketing Manager Sales ManagerSupply Chain Production Manger QA & QC ManagerManager
  16. 16. Career opportunities in Marketing & SalesMarketing & Sales DirectorMarketing Manager Sales ManagerIncharge PMD National Sales ManagerSenior Executive PMD Zonal Sales ManagerExecutive PMD Regional ManagerCustomer Service Manager Area ManagerCustomer Executive Territorial InchargeMR
  17. 17. Refrences• http://www.macleodspharma.com/mfg.htm• http://www.macleodspharma.com/ib.htm• http://www.macleodspharma.com/rd.htm• http://www.macleodspharma.com/intb.htm• http://www.macleodspharma.com/hr.htm

×